Evaluate the Safety and Clinical Activity of HH2853

Clinical trial NCT04390737 · RECRUITING

Trial details

NCT number: NCT04390737
Sponsor: Haihe Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

FL Lymphoma Epithelioid Sarcoma Peripheral T Cell Lymphoma Advanced Solid Tumor

Start date: 2020-09-08
Primary completion: 2027-12-31
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.